article thumbnail

Pfizer issues global market withdrawal of sickle cell disease therapy Oxbryta

Fierce Pharma

Pfizer will voluntarily pull its sickle cell disease drug Oxbryta from all markets worldwide, a major blow to a $5.4 Pfizer will voluntarily pull its sickle cell disease drug Oxbryta from all markets worldwide, a major blow to its $5.4 billion acquisition the New York pharma made two years ago.

Marketing 321
article thumbnail

BioNTech posts €808M loss as company continues to come to grips with seasonal COVID vaccine market

Fierce Pharma

While Pfizer’s German mRNA partner BioNTech has high hopes for its post-COVID future, the company continues to feel the squeeze from the changeover to a seasonal vaccine market.

Marketing 341
article thumbnail

JPM23: Novavax hopes end of COVID emergency—and open vaccine market—will help it grow market share

Fierce Pharma

JPM23: Novavax hopes end of COVID emergency—and open vaccine market—will help it grow market share. aarmstrong. Tue, 01/10/2023 - 10:24.

Marketing 290
article thumbnail

Why DTC isn’t, and is, marketing

World of DTC Marketing

CPG marketers are trying to maintain market share amid price increases and smaller product sizes, leading to a more significant jump in consumerism. But, in pharma marketing, the changes affect every product category. However, DTC marketing is different, much different. So what’s the opportunity for DTC marketers?

Marketing 252
article thumbnail

Data-Driven Marketing 101

This eBook highlights how data-driven strategies empower marketing campaigns through personalization tactics. Here’s what’s covered: How data-driven marketing drives the customer experience. Understanding marketing strategy & performance. The most challenging obstacles to data-driven marketing success.

article thumbnail

At request of AstraZeneca, Europe suspends marketing authorization of COVID vaccine Vaxzevria

Fierce Pharma

On Tuesday, the EMA said it had accepted a request from AZ and withdrawn the company’s marketing authorization for its COVID-19 shot Vaxzevria.

Marketing 321
article thumbnail

Novo, Lilly set to dominate $71B GLP-1 drug market by 2032: J.P. Morgan

Fierce Pharma

Morgan, which has doubled its market projection for GLP-1 diabetes and obesity treatments to $71 billion for 2032. The analysts project Novo and Eli Lilly will dominate the market. . | Promising heart data for Novo Nordisk's Wegovy are a "paradigm shift," according to J.P.

Marketing 308
article thumbnail

Marketing Operations Efficiency: The Essential Checklist

As marketing becomes more tech-driven, the role of marketing operations (MOps) is getting more complex. Today, the discipline is increasingly interwoven with other vital go-to-market motions — including sales and customer support — and is responsible for all business elements associated with marketing, including the tech stack.

article thumbnail

Marketing Ops: The New Revenue Hero

As data continues to play a starring role in today’s B2B organizations, both marketing and sales operations professionals are poised to solidify their place as critical revenue drivers.

article thumbnail

The Ultimate Marketing Efficiency Checklist

When times are tough and marketers are asked to do more with the same (or less), we have to make tough choices. Here are 7 creative ways marketers can work smarter (not harder) - with the resources you already have! However, you might be able to squeeze more value from the tools and processes you’re already using.

article thumbnail

Best Practices for Marketing Database Cleanse

Finding a vendor to cleanse and optimize your marketing database can be difficult if you don’t know what to look for. ZoomInfo has produced this eBook to help marketing leaders understand best practices around cost and value when it comes to choosing a B2B contact data provider. This buyer’s guide will cover: Buying Considerations.

article thumbnail

ABCs of Data Normalization for B2B Marketers

It’s not a far stretch to suggest that the topic isn’t exactly what gets marketers excited in their day-to-day workflow. However, if lead generation, reporting, and measuring ROI is important to your marketing team, then data normalization matters - a lot. Well, marketers rely on this grouping to reach their goals.

article thumbnail

Activating Intent Data for Sales and Marketing

Sales and marketing leaders have reached a tipping point when it comes to using intent data — and they’re not looking back. More than half of all B2B marketers are already using intent data to increase sales, and Gartner predicts this figure will grow to 70 percent. The bad news?

article thumbnail

Marketing-Led Post-COVID-19 Growth Strategies

Any return to normalcy may seem far-off, but sales and marketing are on the front lines of restarting the economy. However, there’s no team better suited to lead that charge than the marketing department. Strategically aligning your systems and teams. Getting consensus on how to define “qualified leads”.

article thumbnail

Your Guide to Using Conversational Marketing to Drive Demand Generation

Enter conversational marketing — the new paradigm to tackling your business deals and converting prospects in minutes. Studies show the return on investment (ROI) of conversational marketing helps your marketing team drive revenue.